toxoplasmosis in the immunocompromised and congenital toxoplasmosis especially known for its ocular and neurological manifestations [4] . Even though infection is common, clinical disease is manifested to a much lesser extent, where most cases are asymptomatic, a condition called latent toxoplasmosis [5] . Although patients that are harboring latent toxoplasmosis are asymptomatic, it was found to be incriminated in the development of mental retardation in children [6] . In addition to the mentioned presentations of toxoplasmosis, recent suggestions implicate T. gondii in other disorders of undefined etiology. Of special interest is its reported link to a group of neuropsychiatric disorders such as autism, bipolar disorder, schizophrenia and degenerative diseases such as Alzheimer's and Parkinson's diseases [7] . Association with these clinical conditions was motivated by the multiple effects of T. gondii on host physiology. Besides, the resulting immunopathological changes, T. gondii is also known to induce neuroendocrine alterations [8, 9] .
Most patients with schizophrenia suffer from a lifetime of disability and about 10% commit suicide [10 ] . The etiology of schizophrenia is thought to be due to several factors. In family studies, genetic factors were found to play a crucial role [11] , whereas epidemiological researches indicated that environmental exposures, such as winter-spring births, peri-and postnatal infections and urban births are risk factors for the development of schizophrenia later in life [12] . Infectious agents, including T. gondii, were considered relevant in triggering schizophrenia [13] . Toxoplasmosis has been linked to schizophrenia through epidemiological data, serological evidence, neuropathological and molecular studies [14] . The causal relationship was speculated to involve susceptibility genes targeting, pro-inflammatory cytokines, neurotransmitters and hormones [15] . It was explained that T. gondii encysted in the host tissues constitutes a source of chronic infection, which leads to the activation of hypothalamic pituitary adrenal axis and subsequently, an increase in glucocorticoid concentration. This increase, in turn, is linked to neurosynaptic degeneration [9] .
Another hormonal change that may explain the link between toxoplasmosis and schizophrenia is the elevation of serum testosterone, which was reported in several studies in Toxoplasma seropositive patients [5, 16, 17] . Alterations of serum testosterone levels have also been found to affect the severity of clinical disease in schizophrenic patients [18] . In addition to neuroendocrine alterations, oxidative stress is one of the mechanisms of pathology that is shared by both schizophrenia and toxoplasmosis. Oxidative stress can be assessed by several markers including malonedialdehyde (MDA), which reflects the degree of lipid peroxidation, and antioxidants such as GSH. MDA was found to be increased in Toxoplasma seropositive patients, while GSH was found to be reduced [19] . In parallel, psychotic patients suffering from schizophrenia and bipolar disorder were shown to have a reduced serum level of glutathione [20] .
To our knowledge, implication of the previously mentioned factors in the pathogenesis of toxoplasmosis and schizophrenia have been studied separately. The causative relation between endocrine changes and oxidative status and these two diseases remain underinvestigated. The current study aims at assessing the seroprevalence/serointensity of toxoplasmosis in schizophrenic patients in relation to the levels of testosterone, cortisol and GSH activity in order to evaluate these factors in schizophrenic patients harboring latent toxoplasmosis.
SuBJEctS And MEtHodS
This is a cross sectional case control study performed during the period from January 2018 to November 20 at Kasr-Al-Ainy Psychiatry and Addiction Hospital and Medical Parasitology Department, Faculty of Medicine, Cairo University, Cairo.
Subjects:
A total number of 240 individuals divided into two equal groups were included in the study. Group 1 included inpatients (case group) ranging in age from 16 to 55 years; while group 2 included individuals attending the outpatients' clinics in the same age range, and after exclusion of schizophrenia. A data collection sheet covering sociodemographic and clinical information was fulfilled before serological testing. Non-cooperative patients, patients with other severe co-morbid disease or history of treatment of toxoplasmosis before sampling were excluded.
Study design:
For psychiatric assessment of case group, diagnosis was confirmed by a structured clinical interview using the statistical manual of mental disorders (DSM) IV axis I disorder (SCID-I) [21] . Psychotic symptom severity was assessed according to PANSS. A general psychopathology scale was also performed. The validity and reliability of the total syndrome (TS) scale (the sum of positive, negative and general scales) was established [22] . ECT was included as a severity marker since it is only indicated for severe cases. Blood samples were collected from both groups for evaluation of the seroprevalence of anti-Toxoplasma IgG, and determination of levels of free testosterone, cortisol and GSH.
Specimen collection and preparation: Three ml venous blood samples obtained by venipuncture were centrifuged at 3000 rpm for 5 min [23] at the Department of Parasitology, Kasr-Al-Ainy School of Medicine and separated sera were frozen until use. Repeated freezing and thawing or heat inactivation were avoided. Insufficient samples or those with incomplete information in the data collection sheet, with hemolysis, turbid or contaminated serum samples, were excluded. Parameters: ELISA was performed according to the manufacturer's instructions as described for Toxoplasma IgG ELISA (Calbiotech Inc, Beta Lab, Cairo, Egypt). For free testosterone and cortisol, ELISA was performed as described by Diametra Inc., and Bioactivia Diagnostic, respectively; both supplied by El-Mottahedeh Inc, Cairo, Egypt. Competitive immunoenzymatic colorimetric method was used for quantitative determination of free testosterone concentration. The cortisol kit used is a solid phase competitive ELISA, in which the intensity of color was considered inversely proportional to the cortisol concentration. Colorimetric method was performed as described for GSH (Bioactivia Diagnostic, El-Mottahedeh Inc, Cairo, Egypt). The method is based on the reduction of 5,5' Dithiobis (2-nitrobenzoic acid) by GSH producing a yellow compound. According to the instruction manual, the reduced chromogen was considered directly proportional to GSH concentration and its absorbance was measured at 405 nm.
Statistical analysis:
Microsoft excel 2013 was used for data entry and the statistical package for social science (SPSS version 24) was used for data analysis. Simple descriptive statistics (arithmetic mean and standard deviation) were used for analysis of normal quantitative data using paired t test, one-way ANOVA and post-hoc tests. Frequencies were used for qualitative data and statistically analyzed by Chi-square and Fisher's exact tests where appropriate. The level of significance was set at probability (P) value <0.05 [24] .
Ethical considerations:
Both schizophrenic and nonschizophrenic patients were properly informed of the purpose of the study and were provided with consent forms. The study was performed in accordance to the ethical guidelines of the Faculty of Medicine, Cairo University; in addition to the approval of the Inpatient Psychiatry Hospital ethical committee.
rESultS
All 120 schizophrenic patients and 120 nonschizophrenic control samples were subjected to measurement of Toxoplasma IgG, cortisol, free testosterone and GSH levels. Table (1) describes data of patients as regards duration of illness, different scales done to assess their schizophrenic illness and history of ECT to assess severity; besides past and family history of psychotic and mood disorders.
No significant difference was recorded between cases group and control group as regard age, gender, occupation, contact with pets, and Toxoplasma IgG seroprevalence (P<0.05). There were significant higher Toxoplasma titers (P=0.049), free testosterone levels in both genders (P<0.001 and 0.005 in males and females, respectively) and cortisol levels (P<0.001) in both groups; while GSH level was significantly lower in cases group than control group (P<0.001) ( Table 2 ).
In tables (3 and 4), Toxoplasma prevalence in schizophrenic cases showed significantly higher rate in male patients than in females (P=0.03), and in rural than in urban areas (P=0.002); while it was significantly lower in patients with history of drug abuse (P=0.005) and patients with positive family history of psychotic disorders (P=0.011). Prevalence was not higher in patients with history of contact with cats. There was no significant difference in patients with positive family history of mood disorders; and there were no significant differences related to positive syndrome scale (PS), negative syndrome scale (NS), general syndrome scale (GS), TS, treatment with ECT or cortisol level. In Toxoplasma positive patients; free testosterone levels in both genders were significantly higher (P<0.001) while GSH was significantly lower (P=0.045). Gender specification showed no significant difference in PS, GS and cortisol level (Table 4 ). While free testosterone levels were found to be significantly higher in male patients receiving ECT (P=0.026), no significant difference was found between ECT and PANSS, cortisol and anti-Toxoplasma IgG. Moreover, no significant difference between drug abuse and the previous mentioned study parameters was detected ( Table 5 ). As regards the family history for mood and psychotic disorders, statistical significance was only detected between the family history for mood disorders and the GSH (P=0.021) ( Table 6 ). Table 5 . PS, NS, GS, TS, Toxoplasma antibody titer, cortisol, free testosterone and GSH levels in relation to ECT and history of drug abuse in schizophrenic patients. 
ECT

diScuSSion
The current study aims to assess the seroprevalence/ serointensity of toxoplasmosis in schizophrenic patients in relation to the levels of free testosterone, cortisol and GSH activity in order to evaluate these factors in schizophrenic patients harboring latent toxoplasmosis. Our results revealing significant higher titers of Toxoplasma in cases group than control group, are assured by other studies [25, 26] that reported the risk of schizophrenia in offspring of mothers with maternal antibodies to toxoplasmosis. Accordingly, this appears to implicate the mothers of our cases group in transplacental transmission of toxoplasmosis. Our result also conforms with a meta-analysis that involved forty-two studies carried out in 17 countries over five decades [27] . Analysis of meta data that included 3873 individuals with schizophrenia and 7046 controls, revealed that individuals with schizophrenia have an increased prevalence of antibodies to T. gondii. Concepts for this statement include that schizophrenia is known to have a genetic component, and that genes are also known to influence the susceptibility of animals to T. gondii. Schizophrenia is believed to be a disease of neurodevelopment, which is consistent with the known ability of T. gondii to cause prenatal infections and remain latent for many years before reactivation. Also while, schizophrenia is known to include abnormalities of neurotransmitters; animal studies have demonstrated an effect of T. gondii on dopamine and serotonin. It is also noticed that there are persistent behavioral changes in Toxoplasmainfected animals [27] .
Leweke et al. [28] reported that the IgG antibody levels in untreated schizophrenic patients were the highest followed by that in treated patients then controls. This was confirmed in other reports [29, 30] in which the prevalence of T. gondii IgG antibodies among patients with schizophrenia was significantly higher than in the controls but not the IgM antibody levels indicating the latency of the infection. Furthermore, other studies [31, 32] observed no significant rise in IgG titer and attributed this to the possible effect of antipsychotic medications in causing a reduction of T. gondii IgG level by inhibiting the replication of T. gondii. Controversially, the study by Khademvatan et al. [33] indicated differences in Toxoplasma antibody seroprevalence between males and females schizophrenic patients, but not between patients with schizophrenia and healthy individuals nor among different subtypes of schizophrenia, various age groups, residential area, or clinical course of treatment.
In our results Toxoplasma prevalence rate in schizophrenic cases was significantly higher in male patients than in females, and in rural than in urban areas. It was significantly lower, and therefore could not be incriminated, in patients with history of drug abuse and patients with positive family history of psychotic disorders. Prevalence was not higher in patients with history of contact with cats which apparently discounts that issue as a risk factor in these patients. Also, no significant difference was recorded in patients with positive family history of mood disorders, in relation to PS, NS, TS, GSH, treatment with ECT, or level of cortisol. Holub et al. [34] confirmed that higher PANSS scores of positive, negative and disorganized psychopathology were associated with lower titer of anti-Toxoplasma antibodies. In addition, it was postulated that due to the presence of the parasites within neurons, hostmediated neuroimmune and hormonal responses to infection are present [8] .
Our results revealed significant higher free testosterone levels (in both genders) and significant higher cortisol levels in cases group than control group. These results conform with the report by Zouei et al. [35] who found that testosterone concentration in toxoplasmosis patients was higher than that in control group with statistically significant difference for men and women. Zghair et al. [36] had previously reported that both acute and chronic toxoplasmosis in males recorded significant higher mean concentration of total and free testosterone. Analysis of our data concerning patients on ECT revealed that free testosterone levels in male patients were significantly higher. However, patients on ECT did not show any other significant relationships with the other parameters. On the other hand, our results were different from those of Eslamirad et al. [17] , and Oktenli et al. [37] who demonstrated significantly lower concentration of total and free testosterone in male patients during acute toxoplasmosis. The authors explained this controversy as due to involvement of different parasite strains with variable virulence and epidemiological occurrence; and concluded that the parasite genotype seems to be an important parameter influencing the clinical infection in humans.
GSH is a non-enzymatic antioxidant that eliminates free radicals and has been suggested to have a role in schizophrenia [19] . We found that the GSH level was significantly lower in cases group than control group, and in the Toxoplasma positive patients it was significantly lower. Our results conform with those of Karaman et al. [19] and Nucifora et al. [20] who found a statistically significant difference between T. gondiiinfected patients and the control group as regard serum MDA, GSH, and nitric oxide levels. While a decrease in GSH activity was detected, MDA and nitric oxide levels increased significantly; and this decrease in GSH level correlated with PANSS total and positive scores for schizophrenia. In our study gender showed no significance concerning PS, GSH and cortisol levels. While NS, TS and Toxoplasma antibody titers were more significant in male patients than females, GSH level was significantly lower, and family history of mood disorders was found to be significantly related to GSH. Family history of psychotic disorders did not show any significant difference and drug abuse did not show any significant relationship.
It was reported that behavioral changes associated with latent Toxoplasma infection are attributed to a presumed increase in neurotransmitters signaling [38] . Therefore, Toxoplasma may play a role in the etiopathogenesis of psychiatric disorders by affecting neurotransmitters which are implicated in the emergence of psychosis and behavioral abnormalities; and by inducing brain inflammation by the direct stimulation of inflammatory cytokines in the central nervous system [39] . Accordingly, neurotransmitterblocking agents have shown some efficacy in the treatment of this pathology. However, the possible association between toxoplasmosis and positive symptoms should be proven by future studies involving neurotransmitters investigations [40] . It can therefore be hypothesized that toxoplasmosis is involved in the etiology of schizophrenia at least partially through the elevation of testosterone and the generation of oxidative stress. Accordingly, it is concluded that in schizophrenic patients, there were high Toxoplasma antibody levels as well as free testosterone and cortisol levels, while there was reduced GSH levels suggesting that latent toxoplasmosis may be involved in the etiology of schizophrenia via neuro-endocrinal alterations. The implication of toxoplasmosis in schizophrenia paves the way to a promising approach to prevention and management of this disease and other psychiatric disorders. This approach adds to the conventional anti-psychotic management strategy by suggesting epidemiological and infectious disease dimension that could provide a background for adjunctive prevention and management plans for patients with schizophrenia.
